Vanderbilt University
Nashville, Tennessee, 37232, United States
NCT Number: NCT01366963
A common complaint among people with Postural Tachycardia Syndrome (POTS) is "brain fog" or difficulty concentrating. This is very poorly understood. To better understand this cognitive dysfunction, the investigators will test people with POTS and people without POTS using various neuropsychiatric instruments. The investigators hypothesis is that people with POTS will have greater abnormalities on neuropsychiatric testing than normal controls.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Observational
Nashville, Tennessee, 37232, United States
Postural Tachycardia Syndrome (POTS) is a disorder that affects an estimated 500,000 people in the United States alone and is an important source of disability in young adults. It shows a strong predilection for females. POTS is a form of orthostatic intolerance characterized by an excessive increase in heart rate (>30 bpm) on assuming the upright position associated with orthostatic symptoms, but in the absence of orthostatic hypotension. Their symptoms of dizziness, nausea, tremor, chronic fatigue and exercise intolerance make even simple activities of daily living exhausting prospects.
Brain fog or cognitive dysfunction is a common and almost universal complaint among persons with POTS. There is a lack of pathophysiological understanding to this cognitive dysfunction and is also a major roadblock to the development of effective therapies for people with POTS.
The purpose of this study is to better define the cognitive dysfunction seen in patients with POTS. We will use a series of validated neuropsychological tools in order to characterize POTS cognitive dysfunction and compare this data to age and gender matched control subjects.
Specific Aims:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All
POTS - additional inclusion criteria - Diagnosed with postural tachycardia syndrome by Vanderbilt Autonomic Dysfunction Center (increase in heart rate greater than or equal to 30 beats per minute with position change from supine to standing (10 minutes; chronic symptoms consistent with POTS that are worse when upright and get better with recumbence.)
Control subjects - additional inclusion criteria
Exclusion criteria
ALL
POTS - additional exclusion criteria
Normal Controls - additional exclusion criteria
The following measurements will take place in a seated position:
Ruff 1 & 7 (visual search and attention processes) Trails A & B (Tests of scanning, mental flexibility and executive processes) Symbol Digit Modalities Test (SDMT)(attention and psychomotor speed) Stroop Test (naming response to certain stimuli) Verbal Fluency (COWA) Randt Wechsler Test of Adult Reading (WTAR)
The following will be measured in a standing position (at least 5 minutes)
Orthostatic Vital Signs Randt Paired Words Subtest Digits Forward and Backward Alternate COWA test
Center for Epidemiologic Studies Depression Scale (CES-D) Cognitive-Somatic Anxiety Questionnaire (CSAQ) Subjective Neurocognitive Inventory (SNI)
Time frame: In the standing position for approximately 15 minutes. This is a cross-sectional study with no follow-up.
This is a continuous variable that will provide a measure of attention with orthostatic stress.
Time frame: At seated and standing. This is a cross-sectional study without follow-up. All assessments are performed on a single day.
The CDS will consist of
1: Seated memory (Randt Short Story subtes, Paired words subtes and Digits Forward) and standing memory (Randt short story, paired words and digits forward).
Vanderbilt University
Other
Origins of Cognitive Dysfunction in Postural Tachycardia Syndrome (POTS)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03681080
Autonomic Failure, Autonomic Nervous System Diseases
Aachen, North Rhine-Westphalia, Germany
View Trial DetailsNCT06268288
Autonomic Dysfunction, Autonomic Nervous System Diseases
Rochester, Minnesota, United States
View Trial DetailsNCT01791816
Autonomic Nervous System Diseases, Consciousness Disorders
Hawthorne, New York, United States
View Trial DetailsNCT04170725
Autonomic Nervous System Diseases, Nervous System Diseases
Bern, Switzerland
View Trial Details